Rockefeller Capital Management’s Global X Genomics & Biotechnology ETF GNOM Stock Holding History
Bought
Maintained
Sold
Other funds holding GNOM
OAM
AAP
SWP
CFD
FIA
Rockefeller Capital Management's GNOM Position: Q2 2026 in Review
Rockefeller Capital Management held its Global X Genomics & Biotechnology ETF (GNOM) position steady in Q2 2026 at 3,107 shares worth $177K. The position accounts for ﹤0.01% of the portfolio, ranked #2670.
Rockefeller Capital Management first reported a position in GNOM in Q3 2020 and has held it in 16 quarters since. The position peaked at $359K in Q2 2023. 48 funds tracked by Wall St. Rank hold GNOM as of Q2 2026.
- Rockefeller Capital Management held 3,107 shares of Global X Genomics & Biotechnology ETF worth $177K as of Q2 2026.
- Rockefeller Capital Management left its Global X Genomics & Biotechnology ETF share count unchanged in Q2 2026.
- Global X Genomics & Biotechnology ETF made up ﹤0.01% of Rockefeller Capital Management's portfolio in Q2 2026, its #2670 holding.
- Rockefeller Capital Management first reported a position in Global X Genomics & Biotechnology ETF in Q3 2020 and has held it in 16 quarters since.
- Rockefeller Capital Management's Global X Genomics & Biotechnology ETF position peaked at $359K in Q2 2023.
- 48 funds tracked by Wall St. Rank held Global X Genomics & Biotechnology ETF as of Q2 2026.
Based on Rockefeller Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.